These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 4865709

  • 21. Baclofen in the treatment of spasticity.
    Hudgson P, Weightman D.
    Br Med J; 1971 Oct 02; 4(5778):15-7. PubMed ID: 4938243
    [Abstract] [Full Text] [Related]

  • 22. Intravenous methocarbamol in 100 orthopedic patients.
    LEVENTEN EO, VACCARINO FP.
    Curr Ther Res Clin Exp; 1960 Oct 02; 2():497-500. PubMed ID: 13761355
    [No Abstract] [Full Text] [Related]

  • 23. [Pharmacological treatment of spasticity in multiple sclerosis].
    Heinzlef O, Monteil-Roch I.
    Rev Neurol (Paris); 2012 Apr 02; 168 Suppl 3():S62-8. PubMed ID: 22721367
    [Abstract] [Full Text] [Related]

  • 24. [Clinical and electromyographic studies on the pharmacological control of spasms].
    Zschocke S, Brune G.
    Verh Dtsch Ges Inn Med; 1965 Apr 02; 71():662-5. PubMed ID: 5877680
    [No Abstract] [Full Text] [Related]

  • 25. Letter: Treatment of spasticity in multiple sclerosis with dantrolene.
    Horne ML.
    JAMA; 1976 Jan 19; 235(3):251. PubMed ID: 946040
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The effect of dantrolene sodium on spasticity in multiple sclerosis.
    Gelenberg AJ, Poskanzer DC.
    Neurology; 1973 Dec 19; 23(12):1313-5. PubMed ID: 4796610
    [No Abstract] [Full Text] [Related]

  • 29. Evaluation of baclofen (Lioresal) for spasticity in multiple sclerosis.
    Hedley DW, Maroun JA, Espir ML.
    Postgrad Med J; 1975 Sep 19; 51(599):615-8. PubMed ID: 1105499
    [Abstract] [Full Text] [Related]

  • 30. Liorseal, a new muscle relaxant in the treatment of spasticity--a double-blind quantitative evaluation.
    Levine IM, Jossmann PB, DeAngelis V.
    Dis Nerv Syst; 1977 Dec 19; 38(12):1011-5. PubMed ID: 338269
    [No Abstract] [Full Text] [Related]

  • 31. A study of metaxalone (Skelaxin) vs. placebo in acute musculoskeletal disorders: a cooperative study.
    Dent RW, Ervin DK.
    Curr Ther Res Clin Exp; 1975 Sep 19; 18(3):433-40. PubMed ID: 810303
    [No Abstract] [Full Text] [Related]

  • 32. Use of methocarbamol for muscle spasm after lumbar and cervical laminectomies.
    POPPEN JL, FLANAGAN ME.
    J Am Med Assoc; 1959 Sep 19; 171():298-9. PubMed ID: 13854387
    [No Abstract] [Full Text] [Related]

  • 33. The management of spasticity in multiple sclerosis.
    DIMSDALE H.
    Physiotherapy; 1961 Apr 10; 47():99-102. PubMed ID: 13722954
    [No Abstract] [Full Text] [Related]

  • 34. V. Pathophysiology, clinical picture, and management of spasticity.
    Khalili AA.
    Clin Anesth; 1967 Apr 10; 3():111-36. PubMed ID: 5584316
    [No Abstract] [Full Text] [Related]

  • 35. [Therapeutic possibilities in spasticity. Review].
    Roşianu C.
    Neurol Psihiatr Neurochir; 1971 Apr 10; 16(1):59-70. PubMed ID: 4253575
    [No Abstract] [Full Text] [Related]

  • 36. Use of diazepam for the relief of spasticity in multiple sclerosis.
    Simpson CA.
    Ann Phys Med; 1964 Apr 10; Suppl():39-40. PubMed ID: 5825182
    [No Abstract] [Full Text] [Related]

  • 37. Baclofen: a preliminary report of its pharmacological properties and therapeutic efficacy in spasticity.
    Brogden RN, Speight TM, Avery GS.
    Drugs; 1974 Apr 10; 8(1):1-14. PubMed ID: 4154834
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.